Prosecution Insights
Last updated: April 19, 2026

Catalent Pharma Solutions Inc.

5 pending office actions • 2 clients

Portfolio Summary

5
Total Pending OAs
3
Final Rejections
2
Non-Final OAs

Client Portfolio (2 clients)

Client (Assignee)Pending OAs
R.P. Scherer Technologies, LLC 3
Catalent U.K. Swindon Zydis Limited 2

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18724812 PHARMACEUTICAL TRIALS SYSTEMS AND METHODS R.P. Scherer Technologies, LLC KANAAN, LIZA TONY 3683 Non-Final OA Jun 27, 2024
18567236 PROTECTIVE COATING FOR MOISTURE SENSITIVE PHARMACEUTICAL COMPOSITIONS R.P. Scherer Technologies, LLC KASSA, TIGABU 1619 Non-Final OA Dec 05, 2023
18140780 DATA ANALYSIS AND REPORTING SYSTEMS AND METHODS R.P. Scherer Technologies, LLC COLEMAN, CHARLES P. 3683 Final Rejection Apr 28, 2023
18030541 STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE Catalent U.K. Swindon Zydis Limited KASSA, TIGABU 1619 Final Rejection Apr 06, 2023
18026529 USE OF SURFACTANT WITH HIGH MOLECULAR WEIGHT FISH GELATIN BASED DOSAGE FORMULATIONS TO IMPROVE FLOW CHARACTERISTICS Catalent U.K. Swindon Zydis Limited PRAGANI, RAJAN 1614 Final Rejection Mar 15, 2023

Managing Catalent Pharma Solutions Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month